T-knife Taps Into Investor Interest in T-Cell Receptor Therapies

Raises $110m In Series B

 
• By Kevin Grogan
  
T Cell lymphocyte with receptors for cancer cell immunotherapy research 3D render
• Source: Archive

More from Financing

More from Business